Pharmaceutical, Biotechnology Industry News

Mon, 22 Sep 2014 16:07:08 -0400

Amgen (NASDAQ: AMGN) today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval for its investigational bispecific T cell engager (BiTE®) antibody construct, blinatumomab....

Thu, 18 Sep 2014 12:44:08 -0400

Baxter International Inc. (NYSE:BAX) today announced that the United States Food and Drug Administration (FDA) has approved RIXUBIS [Coagulation Factor IX (Recombinant)] for routine prophylactic treatment, control and prevention of bleeding...

Thu, 18 Sep 2014 12:22:47 -0400

Baxter International Inc. announced today it is voluntarily recalling one lot of Potassium Chloride Injection 10mEq per 100mL, product code 2B0826 to the hospital/pharmacy/nurse level. The recall is being initiated due to a labeling error on...

Thu, 18 Sep 2014 12:08:00 -0400

Novo Nordisk announced today its support of the National Hemophilia Foundation's (NHF) new three-year initiative, Collaborating in Care, which provides support to people with hemophilia and their families/caregivers to help address the physical...

Thu, 18 Sep 2014 11:53:42 -0400

The Amgen Foundation, in collaboration with European Schoolnet, has launched Amgen Teach, a three-year professional development initiative, designed to further inspire and engage young people’s interest in science by strengthening the ability of...

Wed, 17 Sep 2014 13:28:43 -0400

Microfluidics specialist Dolomite will be launching the Meros TCU-100 at this year’s Lab-on-a-Chip & Microarray World Congress in San Diego, USA, from the 18th to the 19th September. The first module in the new Meros range of plug-and-play...

Tue, 16 Sep 2014 09:49:47 -0400

Amgen (NASDAQ:AMGN) today announced results from a new exploratory analysis of the open-label extension study of the pivotal Phase 3 fracture trial, which found that treatment with Prolia® (denosumab) for eight years enabled a substantial...

Pages